Englerin A, a selective inhibitor of renal cancer cell growth, from Phyllanthus engleri

Org Lett. 2009 Jan 1;11(1):57-60. doi: 10.1021/ol802339w.

Abstract

An extract from Phyllanthus engleri was identified in a bioinformatic analysis of NCI 60-cell natural product extract screening data that selectively inhibited the growth of renal cancer cell lines. Bioassay-guided fractionation yielded two new guaiane sesquiterpenes, englerins A (1) and B (2). Englerin A showed 1000-fold selectivity against six of eight renal cancer cell lines with GI(50) values ranging from 1-87 nM. The structures of 1 and 2 and their relative stereochemistry were established by spectroscopic methods.

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Antineoplastic Agents, Phytogenic / chemistry
  • Antineoplastic Agents, Phytogenic / isolation & purification
  • Antineoplastic Agents, Phytogenic / pharmacology*
  • Biological Assay
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Humans
  • Inhibitory Concentration 50
  • Kidney Neoplasms / pathology*
  • Magnetic Resonance Spectroscopy / standards
  • Molecular Conformation
  • Phyllanthus / chemistry*
  • Plant Bark / chemistry
  • Plant Extracts / chemistry
  • Plant Extracts / isolation & purification
  • Plant Extracts / pharmacology*
  • Plant Stems / chemistry
  • Reference Standards
  • Sesquiterpenes, Guaiane / chemistry
  • Sesquiterpenes, Guaiane / isolation & purification
  • Sesquiterpenes, Guaiane / pharmacology*
  • Stereoisomerism

Substances

  • Antineoplastic Agents, Phytogenic
  • Plant Extracts
  • Sesquiterpenes, Guaiane
  • englerin A